PGY2 Oncology Residency
The Department of Pharmacy at Methodist Healthcare offers a one-year, PGY2 residency in Oncology Pharmacy Practice. The purpose of the Oncology Pharmacy Practice Residency at Methodist University Hospital is to prepare clinical pharmacy specialists with the qualifications needed for inpatient hematology/oncology practice positions and adjunct or non-tenure faculty appointments. The residency will also provide training in hematopoietic stem cell transplant and ambulatory oncology practice.
The Methodist Healthcare Cancer Center in Memphis, Tenn. represents one of the largest providers of cancer diagnosis and treatment in the Mid-South. More than 2,500 newly diagnosed cancer patients are seen annually in the Methodist hospitals. The mission of the Methodist Cancer Center is to exemplify clinical excellence, provide state-of-the-art care, research, and support for every patient accessing care at any point along the continuum, from screening and prevention, treatment, or hospice care.
Residents will practice within the Methodist Cancer Center at Methodist University Hospital, which contains a dedicated 45-bed inpatient oncology unit, an oncology outpatient unit and an inpatient special care unit. An active stem cell transplant program performs ambulatory and inpatient autologous transplants. An interdisciplinary team of oncologists, oncology-certified nurses, social workers, dieticians, clinical pharmacists and clergy focus on both the medical and psychosocial aspects of care. Methodist University Hospital is also partnered with and provides inpatient care for The West Clinic, a National Comprehensive Cancer Network (NCCN) member institution and is a training site for the University of Tennessee Hematology/Oncology Fellowship Program.
The Oncology Pharmacy Residency at Methodist LeBonheur Healthcare - University Hospital (MLH-UH) is a 12-month program developed to satisfy all practice standards established by the American Society of Health-Systems Pharmacists (ASHP). This specialized residency is designed to provide advanced training in hematology/oncology, stem cell transplant, supportive care, research, and teaching. The resident will be actively involved in managing the therapeutic decisions and clinical outcomes of cancer patients in a multi-disciplinary environment. All program participants are expected to:
- Provide pharmaceutical care to cancer patients, applying evidence-based knowledge,
- Possess independent learning skills,
- Possess a professional ethic,
- Possess effective communication skills,
- Possess confident leadership skills,
- Take responsibility for evaluation of one’s work,
- Be capable of providing effective drug education to others,
- Understand and participate in the medication use improvement system,
- Improve the drug distribution system, and
- Take personal responsibility for effecting change through involvement in multidisciplinary and intradepartmental teams.
The specific program for each resident varies based upon his or her goals, interests, and previous experience. However, all residents are required to complete rotations in core areas considered to be essential to the oncology pharmacy practitioner. Elective rotations are available to permit the resident flexibility in pursuing individual goals.
Additional learning experiences aimed at producing a well-rounded oncology pharmacist include the development and completion of a major topic related to pharmacy practice, development of oral and written communications, patient education, participation in various hospital and departmental administrative committees, and dispensing in oncology pharmacy areas. Upon completion of the program, residents are awarded a residency certificate.
Administration of the Program
Residency Program Director
The Director of Pharmacy Services and the Manager of Clinical Pharmacy Services have ultimate responsibility for the residency program. The Director for the Oncology Specialty Residency’s role includes responsibility for ensuring the overall program goals and specific learning objectives are met, training schedules are maintained, appropriate preceptorship for each rotation or training period is provided, and that resident evaluations are conducted routinely and based on the pre-established learning objectives. The program director reports directly to the MLH Pharmacy Residency Preceptors Steering Committee, a committee composed of the directors of residency programs for all Methodist Healthcare residency programs.
The residency coordinator works closely with the program director in all efforts of the residency program. In collaboration with the program director, the coordinator ensures the continuous evaluation of the residency curriculum, goals and objectives, quarterly evaluation of resident progress, the evaluation and support of resident projects, and resident recruitment and selection.
Each rotation has a pharmacist preceptor who develops and guides learning experiences to meet the residency program’s goals and objectives, and with consideration of the resident’s goals, interests and skills. The preceptor periodically reviews the resident’s performance, with a final written evaluation at the conclusion of the learning experience.
The resident is required to complete one major project relating to oncology pharmacy practice. Findings are presented at an annual Pharmacy Resident Conference and written up in manuscript format. A project committee composed of a primary project advisor and at least two other preceptors assists the resident with planning, implementing, analyzing, and presenting the project. The resident shall select a project idea and a primary project advisor within 6 weeks of entering the program. The remainder of the committee shall be selected with three months of entering the program.
In order to attain the core level of knowledge necessary to function as a pharmacy practitioner, each resident will participate in the following rotations:
- Orientation (Initial 2 weeks of residency)
- Hematology/Oncology (5 months, at least 2 of these months must be completed prior to the end of the 2nd Quarter)
- Pain/Palliative Care (1 month)
- Research (1 month, in December)
In addition, the resident will participate in the following longitudinal experiences throughout the year:
- Research project
- Oncology P&T subcommittee
- Oncology Pharmacy Practice experience (staffing in satellite every 4th weekend)
- Oncology On Call (every 4th week)
- Ambulatory Care clinic (one day a week for 4 hours in an outpatient oncology clinic)
Elective rotations may be selected in the following areas:
- Critical Care
- Infectious Diseases
- Malignant Hematology/Stem Cell Transplant
- Medical Oncology
- Pain/Palliative Care
- Practice Management
- Pediatric Oncology
12 months of rotation (11 months if orientation is necessary) providing a structured framework. The resident will meet with the program director at the beginning of the year to form a plan for development. Throughout the year, the resident’s goals may change. Residents may request changes to their rotation schedule with the approval of the preceptors involved and the program director.
Effective communication skills are critical for the pharmacy practitioner. While the resident will have numerous opportunities to refine their skills on rotation, the following experiences are assigned.
- One 40-50 minute presentation on a disease state or other topic of interest is to be presented to preceptors, students, pharmacy staff and other interested individuals at University. The topic is to be selected in conjunction with the Residency Program Director. A Power-Point Presentation and hand-outs are to be developed and used. A ten-minute question/answer session will follow each presentation.
- At least one nursing inservice is to be presented during a Direct Patient Care rotation at University. Topics will be selected in conjunction with the preceptor. Appropriate AV and hand out materials will be developed.
- At least one didactic lecture will be presented to students at the University of Tennessee Health Sciences Center College of Pharmacy. This 50-minute presentation will be accompanied with appropriate AV and hand out materials. The topic will be selected in conjunction with UT faculty.
- The resident’s major project will be presented to the preceptors at University and at a regional resident conference. The presentation is 15-20 minutes long with additional time allotted for questions.
There are numerous opportunities to complete writing assignments throughout the course of the year, including nursing inservices, and written communication to pharmacy staff. The resident is encouraged to write and submit at least one review article or case report for publication during the residency year. Residents must complete a manuscript of their project and submit it to the Residency Program Director before a residency certificate is awarded.
To contribute to their professional growth, each resident shall complete one major project relating to a specific aspect of pharmacy practice. The project may be an original study; a problem-solving exercise; or the development or enhancement of pharmacy services. Results of this project are presented orally in an external forum (to be selected by the Director of the Residency Program) and in a written manuscript suitable for publication (to be selected by the Director of the Residency Program or designee).
Residents will travel, at a minimum, to the ASHP Midyear Clinical Meeting in December, and to a regional residency conference in the spring or the annual Hematology Oncology Pharmacy Association meeting. Residents will receive travel support for attendance at these meetings. Attendance at the ASHP Annual Meeting or other major medical meetings is contingent upon presentation of a project.
All residents are required to become a registered pharmacist in the state of Tennessee within three months of entering the residency program. Evidence of registration must be filed in the Pharmacy Office. Information about Tennessee licensure may be obtained by contacting the Tennessee State Board of Pharmacy at 615.741.2722.
Application Requirements (Application deadline is Jan. 10)
- Letter of intent and CV
- Earned Doctor of Pharmacy degree from ACPE-accredited program
- Three letters of recommendation, including two from clerkship or pharmacy practice residency preceptors
- A completed ASHP Accredited PGY1 Residency is required
An onsite interview will be required contingent on meeting minimum application requirements.
Sundae Stelts, PharmD, BCOP
Director, Oncology Pharmacy Practice Specialty Residency
Pharmacy Clinical Specialist, Malignant Hematology/Hematopoietic Stem Cell Transplantation
Methodist University Hospital
Assistant Professor of Clinical Pharmacy
College of Pharmacy
University of Tennessee HSC
1265 Union Ave, Department of Pharmacy
Memphis, TN 38104
Email: email@example.com (preferred)